BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention

  April 7, 2025

   · 

  4 min read
• Press Releases

  Development of an Innovative Treatment for Parkinson’s disease: Synucure Therapeutics Announces an Investment of $2.8 million

  April 7, 2025

   · 

  3 min read
• Press Releases

  OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma

  April 7, 2025

   · 

  7 min read
• Press Releases

  Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

  April 7, 2025

   · 

  8 min read
• Press Releases

  Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

  April 7, 2025

   · 

  3 min read
• Press Releases

  Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

  April 7, 2025

   · 

  13 min read
• Press Releases

  Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression Association of America (ADAA) 2025 Conference

  April 7, 2025

   · 

  5 min read
• Press Releases

  Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025

  April 7, 2025

   · 

  1 min read
• Press Releases

  Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million

  April 7, 2025

   · 

  4 min read
• Press Releases

  TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

  April 7, 2025

   · 

  14 min read